DAEGU, South Korea, Sept. 11, 2025 /PRNewswire/ — From September 10–12, the 13th Korea International Livestock Exhibition (KISTOCK) was held at Daegu EXCO. Shuying Technology made a standout appearance with its intelligent feeding system, marking the first large-scale overseas implementation of China’s “AI + livestock” technology. This signifies a new phase where China’s livestock technology is shifting from importing expertise to exporting innovation.

As a leading global provider of intelligent pig farming solutions, Shuying showcased a smart feeding suite—comprising a precision feeder, residual feed detector, and intelligent drinking machine—designed to address key challenges in Korean livestock farming: high population density, limited resources, strict environmental policies, and rising labor costs. Its flagship product, the FPF precision feeder, uses an AI nutrition model trained on data from 200,000 sows, controlling feeding error within ≤1% and significantly reducing waste—a tailored “China solution” for Korea’s high-cost market.

In February 2025, Shuying partnered with Yangxiang Group and the South Chungcheong Provincial Government to sign a tripartite agreement promoting smart farming park construction in Korea. This government-level cooperation underscores Shuying’s recognition in high-end international markets.

During the exhibition, Shuying signed smart feeding project agreements with major Korean pig farms such as PigWorld and SINHEUNG farm, expanding its presence in regions like South Chungcheong and North Jeolla. These deals further solidify the company’s strategic footprint in Korea.

The partnerships reflect strong Korean market acceptance of Chinese AI feeding technology. Early adopter Kim Hak-hyeon of Rose Farm shared his experience: “The FPF feeder helped us cut feed waste by 74.2% and greatly improved efficiency.”

Beyond standalone tech exports, Shuying’s FPF Future Pig Farm solution integrates five modules—disease control, decision-making, nutrition, environmental control, and breeding—achieving over 85% smart coverage in multi-story farms. Its space-saving design and doubled labor efficiency are ideally suited to Korea’s land and farming conditions.

CEO Shi Guangxiao stated, “We’re witnessing a historic shift: Chinese smart livestock technology has moved from following, to keeping pace, to leading. Over past decades, China learned from advanced livestock nations like Korea. Today, we’re redefining smart farming with AI to empower global markets.”

To date, Shuying’s FPF system serves over 100 enterprises worldwide with more than 250,000 connected devices. Its launch in Korea is not only an debut achievement for Chinese smart livestock innovation but also a major milestone in the global value export of “AI + agriculture” from China.

Chairman Zhang Yan expressed, “I hope Shuying becomes a symbol of Chinese agricultural tech innovation, spreading homegrown solutions worldwide. We aim to contribute China’s strength to global food security and sustainable development.” Chinese technology, shared with the world.

Independent benchmark analysis finds Clarifai delivers sector-leading speed, flexibility, efficiency, and reliability, powered by compute orchestration.

WASHINGTON, Sept. 11, 2025 /PRNewswire/ — Artificial Analysis, a leading third-party benchmarking platform, today released its API Provider Benchmarking & Analysis report, finding Clarifai’s full-stack AI platform delivered record-setting performance for its hosted gpt-oss-120b model in independent evaluations. With an impressive output speed of 313 tokens per second and a Time to First Token (TTFT) latency of just 0.27 seconds, the groundbreaking results underscore Clarifai as one of the top hardware and GPU-agnostic engines for AI workloads where speed, flexibility, efficiency, and reliability matter most.

Data from the third-party benchmarking firm, Artificial Analysis, shows Clarifai as the best software-first vendor in terms of output speed versus time-to-first-token for gpt-oss-120B

These results highlight Clarifai’s decade-long track record of technical leadership in AI infrastructure. Paired with its industry-leading compute orchestration technology, these capabilities make Clarifai the prime choice for customers and cloud partners that need best-in-class AI performance without being locked into specific hardware vendors.

Clarifai is one of the top vendors among GPU providers to offer gpt-oss-120b, offering unbeatable speed and efficiency. The Clarifai-hosted model shows impressive performance across:

• High Throughput: The gpt-oss-120b delivers a median output speed of 313 tokens per second that surpasses that of every hyperscaler.
• Ultra-Low Latency: It boasts an ultra-low Time to First Token (TTFT) of 0.27 seconds, crucial for real-time and responsive AI applications.
• Unrivaled Cost-Efficiency: With a blended price of just $0.16 per million tokens, it stands as the most cost-efficient option.

These metrics are a testament to Clarifai’s decade-plus of experience in serving production AI workloads for customers of its API. With regular uptimes of 99.99%, the optimized stack Clarifai provides is designed to deliver a high-speed, low-latency end-to-end experience in any compute environment from cloud to on-premise, without sacrificing security or reliability.

“Our team has been relentless in optimizing every layer of the stack, from the model architecture to the end-to-end user experience,” said Matthew Zeiler, Founder & Chief Executive Officer at Clarifai. “These independent benchmarks validate what our customers have already experienced—that our platform is engineered to deliver superior speed while providing the flexibility and efficiency required for modern AI workloads.”

The flexibility of the Clarifai platform is a key differentiator. The company’s compute orchestration capabilities support a variety of deployment environments, including serverless, dedicated instances, and multi-cloud setups, ensuring customers can deploy and scale models with ease. This flexibility is augmented by Local Runners, which allow developers to connect models running on their local machines or private servers directly to Clarifai’s platform via a seamless, publicly accessible API.

Pricing and availability:
The gpt-oss-120b model is available as a hosted offering on the Clarifai platform, noted for its cost efficiency at $0.16 per million tokens. With Local Runners, you can also deploy powerful models on your own dedicated compute, not just in a hosted offering. Clarifai’s model-agnostic platform, which supports a diverse portfolio of models from various creators, enables you to select the optimal model for each task based on your specific needs without vendor lock-in.

Read the entire benchmarking report here.

About Clarifai
Clarifai is a global leader in AI and the pioneer of the full-stack AI platform that helps organizations, teams, and developers build, deploy, and operationalize AI at scale. Clarifai’s cutting-edge AI platform supports today’s modern AI technologies like Large Language Models (LLMs), Large Vision Models (LVMs), Retrieval Augmented Generation (RAG), automated data labeling, high-volume production inference, and more. Founded in 2013, Clarifai is available in cloud, on-premises, or hybrid environments and has been used to build more than 1.5 million AI models, serving more than 500,000 users across 170 countries. Learn more at www.clarifai.com.

For more information or media requests, contact: pr@clarifai.com.

Data from the third-party benchmarking firm Artificial Analysis shows that Clarifai stands out as the most cost-efficient option among software-first vendors, with a blended price of just $0.16 per million tokens.

UDAIPUR, India, Sept. 11, 2025 /PRNewswire/ — Hindustan Zinc Limited, the world’s largest integrated zinc producer, has become the first Indian company to join the International Council on Mining and Metals (ICMM) which creates a landmark that positions India on the global map of responsible mining.

Hindustan Zinc Joins Global Leaders in ICMM, Advancing Sustainable Mining Practices

ICMM brings together 25 of the world’s leading mining and metals companies committed to advancing sustainable development, transparency, and ethical practices. Hindustan Zinc’s admission followed a rigorous independent assessment and endorsement by ICMM’s Council, based on recommendations from the Independent Expert Review Panel. This marks ICMM’s first new member since 2021.

By joining, Hindustan Zinc commits to ICMM’s 40 performance expectations covering Environmental, Social, and Governance (ESG) standards, subject to third-party validation across all assets. Membership reinforces the company’s sustainability leadership and enables collaboration with global peers on climate action, biodiversity, circular economy, and inclusion.

Commenting on the development, Arun Misra, CEO & Whole-time Director, Hindustan Zinc said, “It is both an honor and a big responsibility for Hindustan Zinc to become the first Indian company to join ICMM. This milestone marks a new chapter in our Sustainability 2.0 journey, grounded in transparency, innovation and global best practices. For us, sustainability and good business go hand in hand, and it is a strategic imperative to create lasting positive impact on our environment, our communities, and the industry at large. As we integrate ICMM’s principles across every facet of our operations, we look forward to sharing our insights and gaining perspectives from global peers, contributing to a safer, more responsible future for mining worldwide and the planet.”

Welcoming Hindustan Zinc, Rohitesh Dhawan, President & CEO, ICMM said, “We are pleased to welcome Hindustan Zinc as ICMM’s first Indian member. Their inclusion strengthens our collective commitment to responsible mining and reflects the growing importance of India in the global metals and mining industry. Hindustan Zinc’s leadership in sustainability will add valuable perspectives to our work as we shape a safer and more sustainable future for mining.”

Hindustan Zinc has been recognized globally for its ESG leadership. In 2024, it was ranked the world’s most sustainable metals and mining company by the S&P Global Corporate Sustainability Assessment for the second consecutive year. The company has adopted ambitious 2030 Sustainable Goals, validated Science Based Targets aligned to 1.5°C and is committed to achieving net zero by 2050 or sooner.

Media Contact:

Maitreyee Sankhla
Maitreyee.Sankhla@vedanta.co.in 

Driving the Commercialization of Acoustic Technology in Smart Health Wearables through Solution-Based Service Delivery

BEIJING, Sept. 11, 2025 /PRNewswire/ — Datasea Inc. (NASDAQ: DTSS), a Nevada-based technology company specializing in acoustic high-tech products and AI multimodal digital solutions, today announced that its VIE entity in China, Shuhai Jingwei (Shenzhen) Information Technology Co., Ltd., has signed a service agreement with Hainan Zhixingjian Intelligent Technology Co., Ltd.( “Hainan Zhixingjian”). The two companies will collaborate on the commercialization of acoustic smart health shoes.

Agreement Overview

According to the agreement:

• Contract Term: 12 months
• Technology Output: Datasea will provide proprietary acoustic health hardware and software technology solutions for both adult and children’s smart health insoles. This solution integrates Datasea’s acoustic technology into consumer-grade health wearables, enabling functions such as heating, weight monitoring, ultrasonic sterilization to remove odors, as well as relieving fatigue, improving sleep quality, assisting in the treatment of chronic diseases (such as joint pain), and promoting metabolism, among other key benefits.
• Technology Service Fee: The agreement adopts a usage-based licensing model, with technology service fees calculated based on the cumulative production quantity of products incorporating Datasea’s acoustic technology. During the contract period, Hainan Zhixingjian will pay Datasea RMB 9 per pair (USD 1.26) of shoes produced, including a RMB 1 per pair (USD 0.14) fee for the mini-program usage. If production exceeds 1 million pairs, the service fee will decrease to RMB 7 per pair (USD 0.98). Additionally, if the production target is not met by July 31, 2026, Hainan Zhixingjian will still need to pay a minimum guaranteed service fee of RMB 500,000 (approximately USD 70,224).
• Contract Amount: Based on projected production, Datasea expects to generate up to RMB 7 million (approximately USD 0.98 million) in technology service fees during the contract period. With the expansion of third-party cooperation channels, the contract value is expected to increase further.

Hainan Zhixingjian Intelligent Technology Co., Ltd. is an innovative company focused on the smart health wearables and sports wellness sector. Leveraging the policy and research resources of the Hainan Free Trade Zone, the company has launched a product portfolio including smart shoes, intelligent wellness devices, and digital health platforms, having shipped over 3 million pairs of smart shoes. With more than 50 patents and software copyrights, and rapid marketization capabilities, Hainan Zhixingjian is becoming a leading company in the domestic smart health wearable industry.

“This agreement marks the first batch of orders for Datasea’s acoustic technology embedded in smart health shoes, and represents an important step in the commercialization of our acoustic technology + AI + application scenarios. We are not only entering the fast-growing health wearable market but also validating our acoustic technology licensing + solution-driven profit model. This is a vivid example of the company’s transformation from hardware sales to high-margin solution-driven growth, and a reflection of the company’s strategic focus,” said Zhixin Liu, CEO of Datasea. “By combining acoustic technology with AI, we are able to provide comprehensive technical empowerment in the health sector and establish a replicable, scalable commercialization path using the usage-based licensing model, ultimately forming a sustainable source of recurring revenue.”

At the same time, this cooperation also opens new market opportunities for Datasea further expansion of acoustic technology into the healthcare and consumer sector. As a high-frequency consumer wearable, the smart health shoes have natural user stickiness and significant market scalability, driving Datasea’s acoustic technology into the health, medical monitoring, and lifestyle sectors. Building on the company’s research in acoustic + neural modulation, the solution is expected to extend to brain, heart, and foot reflexology for precision health interventions. This partnership not only highlights the company’s R&D and intellectual property advantages in the field of acoustic health, but also echoes the company’s “acoustic + AI + application scenarios” cross-industry empowerment strategy, embedding acoustic technology as the underlying support for products and services across various industries. It further validates the feasibility and forward-looking nature of its cross-industry applications, which will solidify Datasea’s technical barriers and market leadership.

About Datasea Inc.

Datasea Inc. (“Datasea”) is a leading provider of products, services, and solutions for enterprise and retail customers in two innovative industries, acoustic high tech and 5G-AI multimodal digitalization. The Company’s advanced R&D technology serves as the core infrastructure and backbone for its products. Its 5G multimodal digital segment operates on a cloud platform based on AI. Datasea leverages cutting-edge technologies, precision manufacturing, and ultrasonic, infrasound and directional sound technology in its acoustics business to combat viruses and prevent human infections, and it is also developing applications in medical ultrasonic cosmetology. In July 2023, Datasea established a wholly-owned subsidiary, Datasea Acoustics LLC, in Delaware, in a strategic move to enter the U.S. markets and to mark its global expansion plan. For additional information, please visit www.dataseainc.com.

Cautionary Note Regarding Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will”, “expects”, “anticipates”, “future”, “intends”, “plans”, “believes”, “estimates”, “target”, “going forward”, “outlook,” “objective” and similar terms. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond Datasea’s control, which may cause Datasea’s actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to Datasea as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in Datasea’s filings with the SEC, which are available at www.sec.gov. Datasea does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Investor and Media Contact: 

Datasea Investor Relations
Email:  investorrelations@shuhaixinxi.com
                       sunhezhi@shuhaixinxi.com 

Precept Investor Relations LLC
David Rudnick
+1 646-694-8538
david.rudnick@preceptir.com

CHENGDU, China, Sept. 11, 2025 /PRNewswire/ — Recently, LivingPhoenix®Regenerative Technologies Development (Chengdu) Co., Ltd. (hereinafter “LivingPhoenix Technology”) announced that its independently developed POGMENT triple-helix biomimetic collagen has, for the first time in the world, achieved high-resolution, molecular-level visualization of “collagen fiber bundles” under near-physiological and ultra-low temperature conditions using Cryo-Electron Microscopy (Cryo-EM). This achievement fills an international gap in the structural understanding of collagen fiber self-assembly mechanisms.

POGMENT is recognized as the world’s first triple-helix biomimetic collagen to overcome the challenge of thermal instability. Its production does not rely on animal tissue extraction, classifying it as a fully synthetic collagen material. This innovation addresses the structural and performance limitations traditionally encountered by animal-derived and recombinant collagens. LivingPhoenix Technology’s founder, Qin Xingjiong, stated that the product has filed multiple international and domestic invention patents, has been registered as a patent-intensive product in China, and has already reached factory-scale production—offering a viable collagen alternative for high-end medical aesthetics and regenerative medicine.

Based on Four Chengdu-Based Invention Patents
Providing a Scientific Structural Basis for the Industry

Collagen, the body’s most abundant and widely distributed functional protein, is often referred to as the “scaffolding of life” due to its essential role in supporting skin, bones, and blood vessels. Today’s market primarily offers animal-extracted collagen, recombinant collagen, and biomimetic collagen, with POGMENT belonging to the latter category.

However, as Qin explained, although the importance of collagen has long been recognized in the scientific community, direct high-resolution imaging evidence of the self-assembly process of collagen monomers into functional “collagen fiber bundles” has been lacking—a gap that has impeded further industrial development.

A Chinese research team has now. In collaboration with the Tianfu Jincheng Laboratory (Frontier Medical Center) Cryo-EM platform team, researchers successfully captured the ultrafine structure of self-assembled “collagen fiber bundles” across multiple batches of POGMENT biomimetic collagen products using a 300kV Cryo-Transmission Electron Microscope (Titan Krios G4).

In addition, using a 120kV room-temperature TEM (Talos L120C) alongside negative staining methods, the research team observed numerous batches of samples to reveal distinctive morphological features of the collagen protein. This marks the world’s first instance of high-resolution imaging at the fiber bundle level for collagen, substantiating its natural-like self-assembly ability while unveiling the structural basis underpinning its role as an “active scaffold.” This achievement fills an international gap in the structural comprehension of collagen fiber assembly mechanisms.

The breakthrough is grounded in four invention patents pre-approved by the Chengdu Patent Protection Center: material invention patents ZL202510440051.4, ZL202510440054.8, ZL202410309842.9, and a use invention patent ZL202510391971.1.

“This accomplishment is not only a technical leap in materials science, but also demonstrates China’s original capabilities and strategic depth in the field of biomedical materials,” said Qin Xingjiong. “It lays a solid foundation for the subsequent functional design, industrial conversion, and clinical application of collagen, while providing essential structural scientific evidence for tissue regeneration, aesthetic medicine, anti-aging treatments, and chronic wound repair.”

The product has reached mass production at the factory level,
enabling broad application across multiple scenarios.

POGMENT’s technological evolution is a microcosm of China’s high-end biomedical material innovation. According to Qin, the technology originated from the initial synthetic collagen work (1.0) developed by a Kyoto University research team. Later, through the incorporation of core processes by Dr. Takafumi Takebayashi (version 1.1) and subsequent collaborative R&D between Chinese and Japanese teams, it was successfully localized in Chengdu Tianfu International Bio-Town (version 1.2), representing a crucial transformation and iteration of key technologies in China.

Ultimately, the second-generation independent intellectual property system (version 2.0) was developed by a team of doctoral researchers from the University of Tokyo, Peking University, the Chinese Academy of Sciences, University Paris Dauphine, and other institutions both in China and abroad.

The technology has filed six Chinese invention patents and six PCT international patent applications. To date, it has been granted three substance patents and patent by the China National Intellectual Property Administration, and has completed China’s patent-intensive product certification. Additionally, multiple trademarks and other intellectual property rights have been successfully registered in the United States, the European Union, the United Kingdom, South Korea, and Japan.

Original research co-authored by LivingPhoenix, the Ninth People’s Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Beijing Hospital National Center for Gerontology, Peking University Third Hospital, and the University of Tokyo, among other institutions, has passed peer review and was published in the SCI Q1 journal Frontiers in Bioengineering and Biotechnology (Impact Factor: 4.8). These milestones mark the technology’s entry into a high-standard, high-barrier phase of development.

The project has achieved factory-level mass production. Its unit cost is comparable to that of recombinant collagen, and with the launch of an intelligent factory and further production scale expansion, the annual solution capacity is expected to reach 30 tons. Costs are anticipated to drop to 50% of that of the current recombinant collagen, positioning the product as a high-performance, cost-effective alternative for high-end medical aesthetics and regenerative medicine.

According to research by Head Leopard Research Institute under Frost & Sullivan, China’s biomimetic collagen market is predicted to surge from less than one million yuan in 2025 to 6.778 billion yuan in 2030, with a compound annual growth rate exceeding 150%. Leveraging its structural advantages, POGMENT biomimetic collagen has been officially incorporated into China’s medical industry standard Terminology for Collagen in Tissue-Engineered Medical Devices (YY/T1955-2025), issued by the National Medical Products Administration (NMPA). It has also completed registration in the Medical Device Master File system under the Center for Medical Device Evaluation (CMDE) of the NMPA.

Furthermore, LivingPhoenix Technology has established a classification catalog for injectable freeze-dried biomimetic collagen fibers—covering multiple application scenarios. The product has achieved cross-domain application approval as a Class III medical device and shows potential as a raw material for cosmetics.

For further information on application opportunities in functional cosmetics, medical aesthetics, tissue engineering, or high-end biomedical materials, please contact LivingPhoenix Technology’s official team at:
POGMENT@mylivingphoenix.com 
Official website: www.mylivingphoenix.com

BERLIN, Sept. 11, 2025 /PRNewswire/ — At the 2025 IFA (Internationale Funkausstellung Berlin) in Germany, the debut of Dreame’s world-first dual robotic arm air conditioner X-Wind series, which is awarded the “Technology Innovation Award” by the China Household Electric Appliance Research Institute (CHEARI), has caused a sensation, making Dreame one of the most anticipated brands.

X-Wind series has achieved a breakthrough in “active airflow” with the world’s first dual robotic arm airflow technology. Based on 126° ultra-wide-angle airflow technology, FlexEngine™ millimeter-level control system and deep AI algorithms, X-Wind intelligently switches the wind sensation, providing users with a personalized, comfortable experience. The jury from CHEARI believes that this technology represents the innovative strength of Chinese home appliance brands.

During the exhibition, Dreame’s booth was bustling with people, with many visitors queuing up to experience its intelligent airflow. European dealers said that the zoned airflow and anti-direct blowing design of this air conditioner well meet the high comfort requirement of local families.

Dreame’s robotic arm air conditioner has received extensive attention from international technology media. Journalists and creators from many countries have given positive evaluations of its innovative technology. Chinese media also believe that this foreign debut is a demonstration of Chinese brands’ global innovation power.

IFA is the start of the global push of Dreame Dual Robotic Arm Air Conditioner. Relying on technological accumulation in the field of intelligent robot, Dreame has deeply integrated aerospace-grade algorithms with mechanical design. In the future, it will continue to expand the application of robotic arm technology in the field of air control, providing global users with smarter, healthier air solutions.

Reported by Shuzhi Society.